1. Home
  2. SUPN vs HLX Comparison

SUPN vs HLX Comparison

Compare SUPN & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • HLX
  • Stock Information
  • Founded
  • SUPN 2005
  • HLX 1979
  • Country
  • SUPN United States
  • HLX United States
  • Employees
  • SUPN N/A
  • HLX N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • HLX Oilfield Services/Equipment
  • Sector
  • SUPN Health Care
  • HLX Energy
  • Exchange
  • SUPN Nasdaq
  • HLX Nasdaq
  • Market Cap
  • SUPN 1.9B
  • HLX 1.6B
  • IPO Year
  • SUPN 2012
  • HLX 1997
  • Fundamental
  • Price
  • SUPN $33.84
  • HLX $10.44
  • Analyst Decision
  • SUPN Hold
  • HLX Strong Buy
  • Analyst Count
  • SUPN 1
  • HLX 3
  • Target Price
  • SUPN $36.00
  • HLX $13.67
  • AVG Volume (30 Days)
  • SUPN 334.5K
  • HLX 2.7M
  • Earning Date
  • SUPN 11-06-2024
  • HLX 10-23-2024
  • Dividend Yield
  • SUPN N/A
  • HLX N/A
  • EPS Growth
  • SUPN N/A
  • HLX N/A
  • EPS
  • SUPN 0.08
  • HLX N/A
  • Revenue
  • SUPN $630,163,000.00
  • HLX $1,391,835,000.00
  • Revenue This Year
  • SUPN $4.01
  • HLX $5.60
  • Revenue Next Year
  • SUPN $0.10
  • HLX $3.89
  • P/E Ratio
  • SUPN $447.14
  • HLX N/A
  • Revenue Growth
  • SUPN N/A
  • HLX 24.35
  • 52 Week Low
  • SUPN $21.99
  • HLX $8.82
  • 52 Week High
  • SUPN $35.44
  • HLX $13.05
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 63.14
  • HLX 48.06
  • Support Level
  • SUPN $31.63
  • HLX $10.06
  • Resistance Level
  • SUPN $34.21
  • HLX $10.80
  • Average True Range (ATR)
  • SUPN 0.85
  • HLX 0.43
  • MACD
  • SUPN 0.28
  • HLX -0.04
  • Stochastic Oscillator
  • SUPN 89.09
  • HLX 16.74

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments Well Intervention, Robotics, Production Facilities and Shallow Water Abandonment. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the US.

Share on Social Networks: